Cayuga Biotech
PrivateLast Round
Seed
Dec 11, 2025
Est. Valuation
$3.13M
Total Funding Raised
$8.74M
Company Overview
Cayuga Biotech is a biotechnology company that develops novel therapeutics to address life-threatening hemorrhage and bleeding disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
hemostatic agentbiopharmaceuticalhemorrhage treatmentclotting therapynanoparticle therapeuticstrauma medicinebleeding disordershemostasiscombat casualty carebiomimetic materialspolyphosphate technologyclotting drugbattlefield medicineclinical-stage biotechdrug development
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cayuga Biotech Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Cayuga Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 11, 2025 | ||||
| Accelerator | Jun 2, 2020 | ||||
| Accelerator | May 1, 2020 | ||||
| Grant | Oct 16, 2019 |
Cayuga Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TBD Angels | Seed |
| Defense Health Agency | Grant |
| Wharton Alumni Angels | Seed |
| Walnut Ventures | Seed |
| IndieBio | Accelerator |
| New York Ventures | Seed |
| Purchase Capital | Seed |
Cayuga Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cayuga Biotech's valuation, stock price, and market status.
Firmographic Details
HeadquartersNew York City, New York
Employee Range11
Year Founded2015
Last FundingDec 11, 2025